Could a common drug make cervical cancer screening more effective?
NCT ID NCT06669533
Summary
This study is testing if a medication called misoprostol can help doctors get a better view of the cervix during cancer screening exams. It will involve 420 women who have a cervix that is difficult to examine fully. Participants will be randomly assigned to receive either the study drug or a placebo pill before their screening to see if it improves the exam.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cameroon Baptist Convention Health Core, EtougEbe Baptist Hospital Yaoundé
RECRUITINGYaoundé, Center Region, 2034, Cameroon
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.